It was road rage. Some guy -- maybe he was drunk -- saw a sitting duck with a yellow helmet read more

It was road rage. Some guy -- maybe he was drunk -- saw a sitting duck with a yellow helmet and couldn't resist.

We understand that some groups can be shocked by the publication of certain information, but there are legal means -- read more

We understand that some groups can be shocked by the publication of certain information, but there are legal means -- in Denmark and elsewhere -- to resolve this problem. They can file defamation charges in courts.

The death of junk e-mail will come from a social reason, ... One of two things will happen: No one read more

The death of junk e-mail will come from a social reason, ... One of two things will happen: No one will check their e-mail boxes, or junkers will know no one is reading their e-mail. Either way, the message is not being delivered.

They've known for 16 months that we oppose the concept of additional contract workers at CBC.

They've known for 16 months that we oppose the concept of additional contract workers at CBC.

They are ranked No. 1 for a good reason,

They are ranked No. 1 for a good reason,

Thank you to all the people who helped us get this house.

Thank you to all the people who helped us get this house.

The water is just too bad. The salvage company hired by the insurance is going to take over now.

The water is just too bad. The salvage company hired by the insurance is going to take over now.

Somalis themselves feel that they are under some sort of what they call psychological warfare. They know that at last read more

Somalis themselves feel that they are under some sort of what they call psychological warfare. They know that at last the word is out that Somalia may be a next likely target.

[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, read more

[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, after a slow start, it grew to become a $US2.3 billion ($3 billion today) blockbuster for its owner, Pfizer, in 2003.] About 80 per cent of the prescriptions were for unapproved uses - conditions like bipolar disorder, post-traumatic stress disorder, insomnia, restless legs syndrome, hot flashes, migraines and tension headaches, ... In fact, Neurontin has become a sort of all-purpose restorative for chronic discomfort of almost any type - yet there is almost no good published evidence that it works.